SonoThera Closes Oversubscribed $125 Million Series B Financing to Advance Clinical Development of Ultrasound-Mediated Nonviral Genetic Medicines. Learn more.

SonoThera Targets 2027 for First Clinical Trial of Duchenne Gene Therapy

June 30, 2026

Inquiries about our Clinical Research

Contact Us